Drugs / Tumor Infiltrating Lymphocytes (TILs)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT02652455 | Mar 2016 → Aug 2020 | cutaneous melanoma | H. Lee Moffitt Cancer Center and Research Institute | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tumor Infiltrating Lymphocytes (TILs) | “Tumor Infiltrating Lymphocytes (TILs)” NCT02652455 ↗ |
| Modality | Cell therapy | “Adoptive Cell Therapy” NCT02652455 ↗ |
| Route | Intravenous | “IV infusion of the TIL cells.” NCT02652455 ↗ |